BiotechTube
Home/Kaerus Bioscience/Nicholas Stern
NS

Nicholas Stern

Chief Financial Officer

Kaerus Bioscience

Therapeutic Areas

Neurodevelopmental DisordersRare Genetic Diseases

Kaerus Bioscience Pipeline

DrugIndicationPhase
KER-0193Fragile X syndromePreclinical
BK Channel ModulatorKCNMA1-linked ChannelopathiesPreclinical

Leadership Team at Kaerus Bioscience

RH
Robert H. Ring
Chief Executive Officer
VG
Valentin Gribkoff
Ion Channel Pharmacology
MC
Marc Ceusters
Head of Development
View full Kaerus Bioscience profile